Cover of Penicillin, a book by Ketineni RamaraoFrom the book Penicillin
Chapters 4, 5 and 24. Read the full book free as a PDF.
Timeline in five steps: arsphenamine 1909, penicillin observed 1928, Prontosil 1932, penicillin as a drug in the early 1940s and streptomycin 1943.
Five early steps in antibiotic history. Original IOI diagram.

Before penicillin: finding a chemical that kills microbes

By one count the first antibiotic was arsphenamine, discovered in 1909. That count comes from a 2022 peer-reviewed review that derives a timeline for antibiotic development. The idea was old and simple: find a chemical that harms the microbe more than the patient. For decades most people thought it could not be done. The Nobel Foundation notes that in the 19th century doctors learned that many diseases are caused by microorganisms, which led to the search for chemical preparations to combat them, a challenge "long thought to be impossible".

1932: the sulfa drugs

In 1932 Gerhard Domagk and his colleagues demonstrated in mice that sulfonamides could counteract the bacteria that cause blood poisoning. The Nobel Foundation calls sulfa drugs the first type of antibiotic. Prontosil was the first sulfonamide drug. Domagk won the 1939 Nobel Prize in Physiology or Medicine, but the authorities of his country caused him to decline the award. He later received the diploma and the medal.

Penicillin: seen in 1928, a drug in the 1940s

C&EN's antibacterial timeline records Fleming's discovery in 1928 and notes that penicillin did not become a viable drug until the early 1940s, after work in part by the Oxford team. The factory side of that story is in how penicillin was mass produced.

Waksman's method: look in soil

In 1939 Selman Waksman and colleagues began systematic studies of how microorganisms in soil affect tubercle bacteria. They found that the growth of the tuberculosis bacterium was impeded by another bacterium, Streptomyces griseus. In 1943 Waksman's colleague Albert Schatz isolated streptomycin from it, the first antibiotic effective against tuberculosis. Waksman won the 1952 Nobel Prize alone.

The method is the real legacy: screen soil organisms systematically, grow what shows activity, test it against pathogens. The 2022 review defines the Golden Age of antibiotic discovery as roughly 1940 to 1960, beginning with streptomycin.

The discovery gap

The same review notes that after the Golden Age the rate of discovery fell sharply, and that, as of that 2022 assessment, it was at its lowest since arsphenamine was found in 1909. It counts 38 classes of clinically used antibiotics. The WHO's 2025 pipeline report, its seventh clinical review, evaluates how well the pipeline covers priority pathogens and says its work is part of efforts to address the "ongoing void in antibacterial drug development".

Why the money does not flow

The gap is partly economic. A US government study from the HHS Office of the Assistant Secretary for Planning and Evaluation describes the market for antimicrobials as unusual: it has a positive externality in public health and a negative one in resistance. It reports that over 95 percent of antimicrobial drugs in development are being developed by small companies, and 70 percent of these are pre-revenue, with several large companies having left the field.

The House of Commons Library puts the incentive problem plainly. Companies historically recouped research costs from high sales, but the need to limit use of antibiotics to slow resistance means they cannot rely on sales volumes. England's response is a subscription scheme, called "Netflix for antimicrobials" in the briefing. NHS England pays a fixed annual fee instead of paying per dose. Medicines are placed in one of four bands with fees between £5 million and £20 million a year. In August 2024 the NHS tendered contracts worth almost £1.9 billion over 16 years, with contracts beginning on 1 April 2026.

What to take from the timeline

Three kinds of progress run through it: a chemical idea, a biological source such as soil and moulds, and an industrial method. Penicillin needed all three. Resistance, covered in the history of penicillin resistance, then erodes each new class. The current shortage is not only a scientific problem. It is a payment problem: a drug that works best when used sparingly is hard to sell by the dose.

Quick answers

What was the first antibiotic?

By one count, arsphenamine, discovered in 1909. Prontosil (the first sulfonamide drug) followed in 1932 and penicillin became a drug in the early 1940s.

What was the Golden Age of antibiotics?

Roughly 1940 to 1960, beginning with streptomycin, when most of the main classes of clinically used antibiotics were found.

Who discovered streptomycin?

Albert Schatz isolated it in 1943 in the laboratory of Selman Waksman, who received the 1952 Nobel Prize for it.

Why have so few new antibiotic classes been found recently?

Discovery rates fell sharply after the Golden Age. A US government study also says antimicrobials are hard to sell profitably, and that over 95 percent of drugs in development come from small companies.

Go deeper in the book: Penicillin · PDF · Source Companion · Browse the category

Sources

Timeline dates are from the PMC review, C&EN and the Nobel Foundation pages for Domagk and Waksman. The economics are from the US HHS ASPE study (2022) and the House of Commons Library briefing (2024); US-focused figures there may differ in other markets.

More from this book

Discovery · From the book Penicillin

How penicillin was discovered

Penicillin was seen in 1928 and became a medicine more than a decade later.

Mechanism · From the book Penicillin

How penicillin kills bacteria

Penicillin does not poison a bacterium in the usual sense.

Production · From the book Penicillin

How penicillin was mass produced

In 1940 penicillin could be made in quantities that a laboratory could count in doses.

Resistance · From the book Penicillin

The history of penicillin resistance

Resistance to penicillin is not a late surprise.